TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Expanded Criteria Donors in Liver and Kidney Transplantation: Protocol of a Randomised Single Center Clinical Trial of Hypothermic Oxygenated Perfusion Versus Static Cold Storage
Brief Summary: With the present study the investigators will evaluate the benefit of end-ischemic HOPE on ECD grafts (livers and kidneys) as compared to SCS. Organs will be perfused through a recently developed machine perfusion (MP) device, from the beginning of back-table procedures till implantation, without increasing CIT. The aim of the study will be demonstrating the ability of HOPE to improve graft function and post-operative outcomes of ECD kidney and liver recipients.


Options:
A: Arm Label: OCS Liver System; Type: EXPERIMENTAL; Interventions: Device: OCS™ Liver System | Arm Label: Control; Type: OTHER; Interventions: Other: Control | Intervention Type: DEVICE; Name: OCS™ Liver System; Assigned to Arm(s): OCS Liver System | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
B: Arm Label: Hypothermic oxygenated perfusion (HOPE); Type: EXPERIMENTAL; Interventions: Device: Hypothermic oxygenated perfusion (HOPE) | Arm Label: Conventional cold storage; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional cold storage | Intervention Type: DEVICE; Name: Hypothermic oxygenated perfusion (HOPE); Assigned to Arm(s): Hypothermic oxygenated perfusion (HOPE) | Intervention Type: OTHER; Name: Conventional cold storage; Assigned to Arm(s): Conventional cold storage
C: Arm Label: Hypothermic oxygenated perfusion (HOPE); Type: EXPERIMENTAL; Interventions: Device: Hypothermic oxygenated perfusion (HOPE) | Arm Label: Conventional cold storage (CCS); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional cold storage (CCS) | Intervention Type: DEVICE; Name: Hypothermic oxygenated perfusion (HOPE); Assigned to Arm(s): Hypothermic oxygenated perfusion (HOPE) | Intervention Type: PROCEDURE; Name: Conventional cold storage (CCS); Assigned to Arm(s): Conventional cold storage (CCS)
D: Arm Label: Kidney-Hypothermic oxygenated; Type: EXPERIMENTAL; Interventions: Device: Kidney-Hypothermic oxygenated | Arm Label: Kidney-Static Cold Storage; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Liver-Hypothermic oxygenated; Type: EXPERIMENTAL; Interventions: Device: Liver-Hypothermic oxygenated | Arm Label: Liver-Static Cold Storage; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Kidney-Hypothermic oxygenated; Assigned to Arm(s): Kidney-Hypothermic oxygenated | Intervention Type: DEVICE; Name: Liver-Hypothermic oxygenated; Assigned to Arm(s): Liver-Hypothermic oxygenated

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cervical Cerclage for Singleton Pregnant on Vaginal Progesterone With Progressive Cervical Length Shortening
Brief Summary: The aim of this study is to

Determine whether cerclage with vaginal progesterone will:

1. Reduce the overall spontaneous preterm birth rate.
2. Prolong pregnancy latency.
3. Improve neonatal outcome. Compared to vaginal progesterone only, in patients with progressive cervical shortening.

Research question:

Does cervical cerclage reduce the overall spontaneous preterm births in patients with progressive cervical shortening.

Research Hypothesis In this current study, the investigators hypothesize that cervical cerclage reduces spontaneous preterm births in patients with progressive cervical shortening on vaginal progesterone only.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: N-Acetyl Cysteine | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: N-Acetyl Cysteine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
B: Arm Label: Vaginal progesterone group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Progesterone | Arm Label: No progesterone group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Vaginal progesterone group
C: Arm Label: Vaginal progesterone only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Cervical cerclage plus vaginal progesterone; Type: EXPERIMENTAL; Interventions: Procedure: Cerclage | Intervention Type: PROCEDURE; Name: Cerclage; Assigned to Arm(s): Cervical cerclage plus vaginal progesterone
D: Arm Label: Cervical Pessary; Type: EXPERIMENTAL; Interventions: Device: Cervical pessary | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Cervical pessary; Assigned to Arm(s): Cervical Pessary

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Comparison of Traditional Technique Peripheral Intravenous [PIV] Catheter Insertion to the Utilization of Ultrasound Guidance for the Development of a Vein Classification System and Difficult IV Insertion Algorithm. A Prospective Observational Study
Brief Summary: Hypothesis The initial use of ultrasound guidance when indicated for difficult peripheral IV access will reduce the number of attempts required to achieve successful peripheral IV insertion and improve patient care and satisfaction.


Options:
A: Arm Label: one intervention arm; Type: EXPERIMENTAL; Interventions: Procedure: peripheral venous puncture | Intervention Type: PROCEDURE; Name: peripheral venous puncture; Assigned to Arm(s): one intervention arm
B: Arm Label: Grade 1 Vein Visualization; Type: OTHER; Interventions: Other: IV placement using ultrasound guidance vs traditional method | Arm Label: Grade 2A Vein Visualization; Type: OTHER; Interventions: Other: IV placement using ultrasound guidance vs traditional method | Arm Label: Grade 2b Vein Visualization; Type: OTHER; Interventions: Other: IV placement using ultrasound guidance vs traditional method | Arm Label: Grade 3 Vein Visualization; Type: OTHER; Interventions: Other: IV placement using ultrasound guidance vs traditional method | Intervention Type: OTHER; Name: IV placement using ultrasound guidance vs traditional method; Assigned to Arm(s): Grade 1 Vein Visualization, Grade 2A Vein Visualization, Grade 2b Vein Visualization, Grade 3 Vein Visualization
C: Arm Label: Midline Catheter; Type: EXPERIMENTAL; Interventions: Device: Midline insertion | Arm Label: Peripheral intravenous cannulation (PIVC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Midline insertion; Assigned to Arm(s): Midline Catheter
D: Arm Label: Long Axis approach; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Intravenous access method | Arm Label: Short axis approach; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Intravenous access method | Intervention Type: PROCEDURE; Name: Intravenous access method; Assigned to Arm(s): Long Axis approach, Short axis approach

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Comparison of Traditional Technique Peripheral Intravenous [PIV] Catheter Insertion to the Utilization of Ultrasound Guidance for the Development of a Vein Classification System and Difficult IV Insertion Algorithm. A Prospective Observational Study
Brief Summary: Hypothesis The initial use of ultrasound guidance when indicated for difficult peripheral IV access will reduce the number of attempts required to achieve successful peripheral IV insertion and improve patient care and satisfaction.


Options:
A: Arm Label: Standard Long IV 4.78 cm 20 g catheter; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard Long IV 4.78 cm 20 g catheter | Arm Label: Ultra-Long IV 6.35 cm 20 g catheter; Type: EXPERIMENTAL; Interventions: Device: Ultra-Long IV 6.35 cm 20 g catheter | Intervention Type: DEVICE; Name: Standard Long IV 4.78 cm 20 g catheter; Assigned to Arm(s): Standard Long IV 4.78 cm 20 g catheter | Intervention Type: DEVICE; Name: Ultra-Long IV 6.35 cm 20 g catheter; Assigned to Arm(s): Ultra-Long IV 6.35 cm 20 g catheter
B: Arm Label: Ultrasound-guided peripheral IV.; Type: EXPERIMENTAL; Interventions: Device: Ultrasound | Arm Label: Traditional landmark technique; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Ultrasound; Assigned to Arm(s): Ultrasound-guided peripheral IV.
C: Arm Label: Grade 1 Vein Visualization; Type: OTHER; Interventions: Other: IV placement using ultrasound guidance vs traditional method | Arm Label: Grade 2A Vein Visualization; Type: OTHER; Interventions: Other: IV placement using ultrasound guidance vs traditional method | Arm Label: Grade 2b Vein Visualization; Type: OTHER; Interventions: Other: IV placement using ultrasound guidance vs traditional method | Arm Label: Grade 3 Vein Visualization; Type: OTHER; Interventions: Other: IV placement using ultrasound guidance vs traditional method | Intervention Type: OTHER; Name: IV placement using ultrasound guidance vs traditional method; Assigned to Arm(s): Grade 1 Vein Visualization, Grade 2A Vein Visualization, Grade 2b Vein Visualization, Grade 3 Vein Visualization
D: Arm Label: Ultrasound guided cannulation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Peripheral vein cannulation | Arm Label: Cannulation without ultrasound; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cannulation without ultrasound | Intervention Type: PROCEDURE; Name: Peripheral vein cannulation; Assigned to Arm(s): Ultrasound guided cannulation | Intervention Type: PROCEDURE; Name: Cannulation without ultrasound; Assigned to Arm(s): Cannulation without ultrasound

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Longterm Transfer of FRozen Encapsulated Multidonor Stool Filtrate or Encapsulated Multidonor Microbiome for Chronic Active Ulcerative COlitis
Brief Summary: FRESCO is a randomized, longitudinal, prospective, three arm, multicentre, double blind study to determine safety and efficacy of repeated faecal microbiota transplantation (FMT) or faecal microbiota filtrate transplantation (FMFT) compared to placebo using oral, frozen capsules in 174 randomized patients with mild to moderate active Ulcerative Colitis.


Options:
A: Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Biological: Fecal Microbiota Transplant | Intervention Type: BIOLOGICAL; Name: Fecal Microbiota Transplant; Assigned to Arm(s): Treatment | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Control
B: Arm Label: co-transplantation of FMT and pectin; Type: EXPERIMENTAL; Interventions: Other: co-transplantation of FMT and pectin | Arm Label: single fecal microbiota transplantation; Type: ACTIVE_COMPARATOR; Interventions: Other: single fecal microbiota transplantation | Arm Label: give pectin 20g/d; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: pure give pectin 20g/d for five days | Intervention Type: OTHER; Name: co-transplantation of FMT and pectin; Assigned to Arm(s): co-transplantation of FMT and pectin | Intervention Type: OTHER; Name: single fecal microbiota transplantation; Assigned to Arm(s): single fecal microbiota transplantation | Intervention Type: DIETARY_SUPPLEMENT; Name: pure give pectin 20g/d for five days; Assigned to Arm(s): give pectin 20g/d
C: Arm Label: faecal microbiota filtrate; Type: EXPERIMENTAL; Interventions: Drug: encapsulated faecal microbiota filtrate | Arm Label: faecal microbiota; Type: ACTIVE_COMPARATOR; Interventions: Drug: encapsulated faecal microbiota | Arm Label: Placebo; Type: SHAM_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: encapsulated faecal microbiota filtrate; Assigned to Arm(s): faecal microbiota filtrate | Intervention Type: DRUG; Name: encapsulated faecal microbiota; Assigned to Arm(s): faecal microbiota | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Fecal Microbiota Enema; Type: EXPERIMENTAL; Interventions: Biological: Fecal Microbiota Enema | Arm Label: Normal Saline Enema; Type: PLACEBO_COMPARATOR; Interventions: Biological: Normal Saline Enema | Intervention Type: BIOLOGICAL; Name: Fecal Microbiota Enema; Assigned to Arm(s): Fecal Microbiota Enema | Intervention Type: BIOLOGICAL; Name: Normal Saline Enema; Assigned to Arm(s): Normal Saline Enema

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of the Prescription of 10,000 Steps a Day Using a Pedometer Via Mobile APP, Through a Goal Setting System, in the Body Composition of Overweight Adults: a 6-Month Randomized Weight Loss and mHealth Trial.
Brief Summary: This study aimed the effect of the Accupedo pedometer smartphone app intervention, with goal setting of walking prescription of 10,000 steps per day, in overweight adults.


Options:
A: Arm Label: Telemonitoring group; Type: EXPERIMENTAL; Interventions: Procedure: Telemonitoring | Arm Label: Control group; Type: OTHER; Interventions: Other: control group | Intervention Type: PROCEDURE; Name: Telemonitoring; Assigned to Arm(s): Telemonitoring group | Intervention Type: OTHER; Name: control group; Assigned to Arm(s): Control group
B: Arm Label: Control Group (CG); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control Group (CG) | Arm Label: Intervention Group (IG); Type: EXPERIMENTAL; Interventions: Behavioral: Intervention Group (IG) | Intervention Type: BEHAVIORAL; Name: Control Group (CG); Assigned to Arm(s): Control Group (CG) | Intervention Type: BEHAVIORAL; Name: Intervention Group (IG); Assigned to Arm(s): Intervention Group (IG)
C: Arm Label: Social/Mobile Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Social/mobile weight loss promotion intervention. | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Social/mobile weight loss promotion intervention.; Assigned to Arm(s): Social/Mobile Intervention
D: Arm Label: RIDE; Type: EXPERIMENTAL; Interventions: Behavioral: RIDE e-health application | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: RIDE e-health application; Assigned to Arm(s): RIDE

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tele Follow-up Using Patient-reported Outcomes (PRO) Measures in Patients With Chronic Kidney Disease - the PROKID Study
Brief Summary: This randomized controlled trial (RCT) will evaluate if PRO-based follow-up is at least as effective as usual outpatient follow-up in managing decline in renal function and maintaining patients' quality of life. Furthermore, we intend to characterize the target patient group that is suitable for PRO-based follow up in a group of patients suffering from renal insufficiency.


Options:
A: Arm Label: Questionnaire and feedback; Type: OTHER; Interventions: Other: Questionnaire and feedback | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Questionnaire and feedback; Assigned to Arm(s): Questionnaire and feedback
B: Arm Label: Personal counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Personal Counseling | Arm Label: Computer generated feedback letters; Type: EXPERIMENTAL; Interventions: Behavioral: Computer-generated feedback letters | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Personal Counseling; Assigned to Arm(s): Personal counseling | Intervention Type: BEHAVIORAL; Name: Computer-generated feedback letters; Assigned to Arm(s): Computer generated feedback letters
C: Arm Label: Feedback Group; Type: EXPERIMENTAL; Interventions: Other: Feedback Group | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Feedback Group; Assigned to Arm(s): Feedback Group
D: Arm Label: PRO-based follow-up; Type: EXPERIMENTAL; Interventions: Behavioral: PRO-based follow-up | Arm Label: PRO-based telephone consultations; Type: EXPERIMENTAL; Interventions: Behavioral: PRO-based telephone consultation | Arm Label: Usual outpatient follow-up visits; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: PRO-based follow-up; Assigned to Arm(s): PRO-based follow-up | Intervention Type: BEHAVIORAL; Name: PRO-based telephone consultation; Assigned to Arm(s): PRO-based telephone consultations

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improvement of Medicine Adherence and the Following Positive Effects on Transplants in Patients After Organ Transplantation With Pilloxa's Electronic Pillbox
Brief Summary: Poor adherence to medication among patients with chronic diseases is a major problem. A patient group where the adherence to prescribed medications is extremely important are organ transplanted patients. It is well established that lack of adherence to immunosuppressive medication drastically increases the risk of rejection reactions, graft loss and deaths.

Pilloxa is a device meant to help users manage medication and support adherence to medication. This study evaluates if Pilloxa improves adherence to treatment for transplanted patient compared with conventional management. Patients who have received a transplanted kidney or liver will be studied.

Pilloxa is a system comprising of: a box with 14 separate containers to temporarily store tablets/capsules in and that can be open by 14 independent lids, a smartphone application and cloud based servers. The pillbox will at given times detect if pills are present in the different compartments and can connect, send and receive information to/from mobile application and the cloud.


Options:
A: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: mHealth Intervention; Type: EXPERIMENTAL; Interventions: Other: mHealth Intervention | Intervention Type: OTHER; Name: mHealth Intervention; Assigned to Arm(s): mHealth Intervention
B: Arm Label: Pilloxa Pillbox; Type: EXPERIMENTAL; Interventions: Device: Pilloxa Pillbox | Arm Label: Non active Pilloxa Pillbox; Type: SHAM_COMPARATOR; Interventions: Other: Non active Pilloxa Pillbox | Intervention Type: DEVICE; Name: Pilloxa Pillbox; Assigned to Arm(s): Pilloxa Pillbox | Intervention Type: OTHER; Name: Non active Pilloxa Pillbox; Assigned to Arm(s): Non active Pilloxa Pillbox
C: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: internet mobile application; Type: ACTIVE_COMPARATOR; Interventions: Device: internet mobile application | Intervention Type: DEVICE; Name: internet mobile application; Assigned to Arm(s): internet mobile application
D: Arm Label: Group CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive-behavioral adherence promotion program | Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Care | Intervention Type: BEHAVIORAL; Name: Cognitive-behavioral adherence promotion program; Assigned to Arm(s): Group CBT | Intervention Type: BEHAVIORAL; Name: Standard Care; Assigned to Arm(s): Standard Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Double-blind, Randomized, Parallel-group, Active Control Study to Compare the Efficacy, Safety, and Immunogenicity of AVT02 Versus Humira® in Patients With Moderate-to-Severe Chronic Plaque Psoriasis (ALVOPAD PS)
Brief Summary: Safety and Efficacy study of AVT02 (Alvotech Biosimilar to Adalimumab), in patients with moderate to severe plaque psoriasis.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: CZP 200 mg; Type: EXPERIMENTAL; Interventions: Other: Placebo, Drug: Certolizumab Pegol | Arm Label: CZP 400 mg; Type: EXPERIMENTAL; Interventions: Drug: Certolizumab Pegol | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): CZP 200 mg, Placebo | Intervention Type: DRUG; Name: Certolizumab Pegol; Assigned to Arm(s): CZP 200 mg, CZP 400 mg
B: Arm Label: Group A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Etanercept | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Drug: Etanercept + Acitretin | Arm Label: Group C; Type: ACTIVE_COMPARATOR; Interventions: Drug: Acitretin | Intervention Type: DRUG; Name: Etanercept; Assigned to Arm(s): Group A | Intervention Type: DRUG; Name: Etanercept + Acitretin; Assigned to Arm(s): Group B | Intervention Type: DRUG; Name: Acitretin; Assigned to Arm(s): Group C
C: Arm Label: AVT02 100mg/mL (Adalimumab Biosimilar); Type: EXPERIMENTAL; Interventions: Biological: Adalimumab | Arm Label: EU-Humira 100mg/mL (Adalimumab Originator); Type: EXPERIMENTAL; Interventions: Biological: Adalimumab | Intervention Type: BIOLOGICAL; Name: Adalimumab; Assigned to Arm(s): AVT02 100mg/mL (Adalimumab Biosimilar), EU-Humira 100mg/mL (Adalimumab Originator)
D: Arm Label: BI 695501; Type: EXPERIMENTAL; Interventions: Drug: BI 695501 | Arm Label: Humira; Type: ACTIVE_COMPARATOR; Interventions: Drug: Humira | Intervention Type: DRUG; Name: BI 695501; Assigned to Arm(s): BI 695501 | Intervention Type: DRUG; Name: Humira; Assigned to Arm(s): Humira

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Mirror Therapy on Unilateral Neglect for Patients After Stroke
Brief Summary: This is a single-blinded randomized controlled trial to investigate the effects of mirror therapy (MT), with reference to sham mirror (a glass wall) and control (a covered mirror), in reducing unilateral neglect for patients with stroke in 2 centres.


Options:
A: Arm Label: Optimization of OKS; Type: EXPERIMENTAL; Interventions: Device: OKS | Arm Label: Safety and efficacy study; Type: EXPERIMENTAL; Interventions: Device: OKS | Arm Label: Effect of repetitive stimulation; Type: EXPERIMENTAL; Interventions: Device: OKS | Arm Label: OKS and gait; Type: EXPERIMENTAL; Interventions: Device: OKS | Intervention Type: DEVICE; Name: OKS; Assigned to Arm(s): Effect of repetitive stimulation, OKS and gait, Optimization of OKS, Safety and efficacy study
B: Arm Label: Family-Clinician Collaboration; Type: EXPERIMENTAL; Interventions: Behavioral: Family-Clinician Collaboration Program | Intervention Type: BEHAVIORAL; Name: Family-Clinician Collaboration Program; Assigned to Arm(s): Family-Clinician Collaboration
C: Arm Label: High frequency rTMS plus fNIRS; Type: EXPERIMENTAL; Interventions: Device: Functional near infrared spectroscopy, Device: rTMS | Arm Label: Sham rTMS; Type: SHAM_COMPARATOR; Interventions: Device: rTMS | Arm Label: High frequency rTMS; Type: EXPERIMENTAL; Interventions: Device: rTMS | Intervention Type: DEVICE; Name: Functional near infrared spectroscopy; Assigned to Arm(s): High frequency rTMS plus fNIRS | Intervention Type: DEVICE; Name: rTMS; Assigned to Arm(s): High frequency rTMS, High frequency rTMS plus fNIRS, Sham rTMS
D: Arm Label: Mirror therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Mirror therapy | Arm Label: Sham mirror; Type: SHAM_COMPARATOR; Interventions: Behavioral: Sham mirror | Arm Label: Covered mirror; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Covered mirror | Intervention Type: BEHAVIORAL; Name: Mirror therapy; Assigned to Arm(s): Mirror therapy | Intervention Type: BEHAVIORAL; Name: Sham mirror; Assigned to Arm(s): Sham mirror | Intervention Type: BEHAVIORAL; Name: Covered mirror; Assigned to Arm(s): Covered mirror

Answer: D